MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
StockStory.org on MSN
A look back at drug development inputs & services stocks’ Q4 earnings: Repligen (NASDAQ:RGEN) vs the rest of the pack
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating tremendous costs for clinical studies, it also raises significant ethical ...
Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster.
Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic diseases. But the deal is a little different compared to many recent deals ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...
HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the animal testing requirement for monoclonal antibodies. A few months later, ...
Patients with obesity sometimes have leptin resistance, and the "full" feeling does not get through to the brain. The new ...
Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...
In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results